Poetic talent unmasked by treatment of Parkinson's disease
Identifieur interne : 004719 ( Main/Exploration ); précédent : 004718; suivant : 004720Poetic talent unmasked by treatment of Parkinson's disease
Auteurs : Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-11.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Agonist, Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Antiparkinson agent, Artist, Case study, Chemotherapy, Creativity, Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Dopamine receptor, Ergot derivatives, Evolution, Human, Humans, Levodopa, Levodopa (pharmacology), Libido (drug effects), Lisuride, Lisuride (pharmacology), Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (psychology), Parkinson disease, Poetry, Poetry as Topic, Serotonin Receptor Agonists (pharmacology), Serotonin Receptor Agonists (therapeutic use).
- MESH :
- chemical , pharmacology : Antiparkinson Agents, Dopamine Agonists, Levodopa, Lisuride, Serotonin Receptor Agonists.
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Serotonin Receptor Agonists.
- drug effects : Libido.
- drug therapy : Parkinson Disease.
- psychology : Parkinson Disease.
- Creativity, Humans, Male, Middle Aged, Poetry as Topic.
Abstract
Parkinson's disease is typically characterised by loss of function and previous abilities, often accompanied by complications of treatment in later stages of the disease. We report on a patient who newly developed an artistic skill after starting treatment for Parkinson's disease. This case offers insight into the neurology of the artistic process as well as into the pathophysiology of psychiatric adverse reactions to the treatment of PD. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/mds.1239
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001958
- to stream Istex, to step Curation: 001958
- to stream Istex, to step Checkpoint: 002F46
- to stream Main, to step Merge: 006C01
- to stream PascalFrancis, to step Corpus: 002903
- to stream PascalFrancis, to step Curation: 000418
- to stream PascalFrancis, to step Checkpoint: 002927
- to stream Main, to step Merge: 006E26
- to stream PubMed, to step Corpus: 003C19
- to stream PubMed, to step Curation: 003C19
- to stream PubMed, to step Checkpoint: 003C69
- to stream Ncbi, to step Merge: 000632
- to stream Ncbi, to step Curation: 000632
- to stream Ncbi, to step Checkpoint: 000632
- to stream Main, to step Merge: 006971
- to stream Main, to step Curation: 004719
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Poetic talent unmasked by treatment of Parkinson's disease</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</author>
<author><name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/mds.1239</idno>
<idno type="url">https://api.istex.fr/document/6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001958</idno>
<idno type="wicri:Area/Istex/Curation">001958</idno>
<idno type="wicri:Area/Istex/Checkpoint">002F46</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006C01</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:02-0176264</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002903</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000418</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002927</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006E26</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11748756</idno>
<idno type="wicri:Area/PubMed/Corpus">003C19</idno>
<idno type="wicri:Area/PubMed/Curation">003C19</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C69</idno>
<idno type="wicri:Area/Ncbi/Merge">000632</idno>
<idno type="wicri:Area/Ncbi/Curation">000632</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000632</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Schrag A:poetic:talent:unmasked</idno>
<idno type="wicri:Area/Main/Merge">006971</idno>
<idno type="wicri:Area/Main/Curation">004719</idno>
<idno type="wicri:Area/Main/Exploration">004719</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Poetic talent unmasked by treatment of Parkinson's disease</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Raymond Way Neuropsychiatry Research Group, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Raymond Way Neuropsychiatry Research Group, Institute of Neurology, University College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-11">2001-11</date>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1175">1175</biblScope>
<biblScope unit="page" to="1176">1176</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC</idno>
<idno type="DOI">10.1002/mds.1239</idno>
<idno type="ArticleID">MDS1239</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antiparkinson agent</term>
<term>Artist</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Creativity</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Dopamine receptor</term>
<term>Ergot derivatives</term>
<term>Evolution</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (pharmacology)</term>
<term>Libido (drug effects)</term>
<term>Lisuride</term>
<term>Lisuride (pharmacology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Poetry</term>
<term>Poetry as Topic</term>
<term>Serotonin Receptor Agonists (pharmacology)</term>
<term>Serotonin Receptor Agonists (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
<term>Lisuride</term>
<term>Serotonin Receptor Agonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Serotonin Receptor Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Libido</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Creativity</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Poetry as Topic</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Agoniste</term>
<term>Antiparkinsonien</term>
<term>Artiste</term>
<term>Chimiothérapie</term>
<term>Ergot dérivé</term>
<term>Etude cas</term>
<term>Evolution</term>
<term>Homme</term>
<term>Lisuride</term>
<term>Lévodopa</term>
<term>Parkinson maladie</term>
<term>Poésie</term>
<term>Récepteur dopaminergique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease is typically characterised by loss of function and previous abilities, often accompanied by complications of treatment in later stages of the disease. We report on a patient who newly developed an artistic skill after starting treatment for Parkinson's disease. This case offers insight into the neurology of the artistic process as well as into the pathophysiology of psychiatric adverse reactions to the treatment of PD. © 2001 Movement Disorder Society.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</region>
<name sortKey="Trimble, Michael" sort="Trimble, Michael" uniqKey="Trimble M" first="Michael" last="Trimble">Michael Trimble</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004719 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004719 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:6B926782EB0AA7C9D6EF1ED8EC6906ECA2DEE4DC |texte= Poetic talent unmasked by treatment of Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |